NEW YORK (360Dx) – Siemens, Quidel, Becton Dickinson, and Roche were among several companies receiving US Food and Drug Administration clearances for tests in February.

Among the test clearances for cancer diagnostics, Roche received clearance at the end of the month for its Elecsys tumor-associated antigen immunological assay. It is intended to aid in the management of breast cancer patients through quantitative determination of CA 153 in human serum and Li-heparin plasma.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.